Fewer brain lesions with AZT

An eleven-year Norwegian autopsy study found fewer brain lesions in people who died of AIDS complications who had used AZT until death. Previous studies contradict this result. The Norwegian researchers believe that the inclusion of data prior to AZT availability led to the inconclusive findings.